← Open Payments lookup

LYNN SWANSON: Open Payments

NPI 1073082343 · BERLIN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$269 in 12 payments from 8 companies in 2025. Trend: 2023 $169 · 2024 $41 · 2025 $269

Food & beverage: $269
CompanyPaymentsAmount
Alkermes, Inc.3$65
Otsuka America Pharmaceutical, Inc.2$43
Takeda Pharmaceuticals U.S.A., Inc.1$39
REVANCE THERAPEUTICS, INC.2$36
ABBVIE INC.1$23
Solta Medical, a division of Bausch Health US, LLC1$23
Lundbeck LLC1$21
Gilead Sciences, Inc.1$20

Products named: REXULTI, ARISTADA, TRINTELLIX, DAXXIFY, VIVITROL.

Industry payments across CT — which companies pay providers there.